The Double-Efficacy to Evaluate the Spectrum-Effect Relationship of Blood Enriching Function of Buzhongyiqi Wan

胡芳,杨英来,刘小花,李灿,朱瑞娟,封士兰
DOI: https://doi.org/10.13412/j.cnki.zyyl.2013.05.006
2013-01-01
Abstract:Objective: To analyze the correlation of different batches of Buzhongyiqi Wan between HPLC fingerprints and blood enriching,to establish its medicinal components group of blood enriching function. Method: Copy a mouse mode of blood deficiency by subcutaneous injection hydracetin( APH); Solid phase extraction small column for purification of the samples of Buzhongyiqi Wan,build HPLC-DAD and HPLCELSD fingerprint; select hematocrit( HCT) and liver weight index as the pharmacodynamic indicators,study the spectrum-effect relationship using gray relational grade method. Results: 21 common peaks in the HPLC-DAD fingerprint and 10 common peaks in the HPLC-ELSD were found. Their contribution order to blood enriching function in HPLC-DAD fingerprint is( characteristic peak number) : 7 > 8 > 11 > 6 > 4 > 9 > 19 > 14 > 1 > 13 > 16 > 15 > 18 > 5 > 3 > 12 > 17 > 2 > 21 > 10 > 20,NO. 11,12,18,19,21 is hesperidin,senkyunolide I,calycosin, formononetin,ligustilide respectively. Their contribution order of blood enriching function in HPLC--ELSD fingerprint is( characteristic peak number) : 1 > 6 > 4 > 2 > 9 > 5 > 10 > 8 > 3 > 7,peak 4 and 8 respectively is hesperidin and astragaloside IV. Conclusion: 10 batches of the Buzhongyiqi Wan( dose: 1g / kg) have good improvement for APH caused blood deficiency symptoms. Their are certain corresponding relation between HPLC fingerprint and the role of the blood,so as HPLC-ELSD fingerprint.
What problem does this paper attempt to address?